• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Malabsorption Syndrome Market

    ID: MRFR/Pharma/11792-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Malabsorption Syndrome Market Trends And Share Analysis By Diagnosis (Tests, Imaging), Causative Diseases (Lactose Intolerance, Sprue, Cystic Fibrosis), Treatment (Gluten-Free Diet, Antidiarrheal Agents, Anti-Inflammatory Drugs), End User – Global Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Malabsorption Syndrome Market Infographic
    Purchase Options

    US Malabsorption Syndrome Market Summary

    The US Malabsorption Syndrome market is projected to grow from 12.5 USD Billion in 2024 to 20.3 USD Billion by 2035.

    Key Market Trends & Highlights

    US Malabsorption Syndrome Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.51 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 20.3 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 12.5 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic techniques due to increasing awareness of malabsorption conditions is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.5 (USD Billion)
    2035 Market Size 20.3 (USD Billion)
    CAGR (2025 - 2035) 4.51%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Malabsorption Syndrome Market market include

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 NA (USD Billion)
    Market Size 2024 NA (USD Billion)
    Market Size 2032 NA (USD Billion)
    Compound Annual Growth Rate (CAGR) NA % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US)
      Key Market Opportunities   Infrastructural chain
      Key Market Drivers   Growing prevalence of lactose intolerance

    FAQs

    What is the expected market size of the US Malabsorption Syndrome Market in 2024?

    The US Malabsorption Syndrome Market is expected to be valued at 44.1 million USD in 2024.

    What will be the projected market size of the US Malabsorption Syndrome Market by 2035?

    By 2035, the US Malabsorption Syndrome Market is anticipated to reach a valuation of 1005.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Malabsorption Syndrome Market from 2025 to 2035?

    The market is expected to experience a CAGR of 32.871% from 2025 to 2035.

    Which key players are leading the US Malabsorption Syndrome Market?

    Major players include Merck and Co, Genentech, AstraZeneca, and Bristol-Myers Squibb among others.

    What is the valuation of the US Malabsorption Syndrome Market for Tests in 2024?

    The market for Tests under the US Malabsorption Syndrome segment is valued at 18.8 million USD in 2024.

    What will the valuation of the Imaging segment be in the US Malabsorption Syndrome Market by 2035?

    The Imaging segment is projected to be valued at 554.7 million USD in 2035.

    What is the market value of Tests in the US Malabsorption Syndrome Market in 2035?

    By 2035, the market for Tests is expected to reach 450.3 million USD.

    What are the emerging trends in the US Malabsorption Syndrome Market?

    Emerging trends include advancements in diagnostics and increasing awareness of malabsorption disorders.

    How does regionality play a role in the growth of the US Malabsorption Syndrome Market?

    The US demonstrates substantial growth opportunities driven by an aging population and rising healthcare expenditures.

    What challenges does the US Malabsorption Syndrome Market face?

    Challenges include high costs of treatment and variability in diagnosis leading to potential patient mismanagement.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials